Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Knowles

Showing results (241-250 of 315) with videos related to

Pageof 32
Sort By:
Genome Biology|December 23, 2006
Three-dimensional morphology and gene expression in the Drosophila blastoderm at cellular resolution I: data acquisition pipelineCris L Luengo Hendriks, Soile V E Keränen, Charless C Fowlkes, et al.
The Lancet. Diabetes & Endocrinology|December 21, 2025
Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trialFrederick J Raal, Jean Bergeron, Daniel Gaudet, et al.
Circulation. Genomic and Precision Medicine|February 10, 2022
Coronary Artery Disease Risk of Familial Hypercholesterolemia Genetic Variants Independent of Clinically Observed Longitudinal Cholesterol ExposureShoa L Clarke, Catherine Tcheandjieu, Austin T Hilliard, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 30, 2015
A second transmissible cancer in Tasmanian devilsRuth J Pye, David Pemberton, Cesar Tovar, et al.
Nature Medicine|August 25, 2023
RNA interference targeting ANGPTL3 for triglyceride and cholesterol lowering: phase 1 basket trial cohortsGerald F Watts, Christian Schwabe, Russell Scott, et al.
Circulation|July 21, 2022
Creation of the American Heart Association Journals' Equity, Diversity, and Inclusion Editorial Board: The Next Step to Achieving the 2024 Impact GoalEldrin F Lewis, Christine Beaty, Johannes Boltze, et al.
The Journal of Pediatrics|September 25, 2020
Children with Heterozygous Familial Hypercholesterolemia in the United States: Data from the Cascade Screening for Awareness and Detection-FH RegistrySarah D de Ferranti, Peter Shrader, MacRae F Linton, et al.
Human Molecular Genetics|April 30, 2008
Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE studyThemistocles L Assimes, Joshua W Knowles, Analabha Basu, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 23, 2025
Primary care providers' perspectives on receiving opportunistic genomic results from a national study: The Million Veteran Program Return Of Actionable Results (MVP-ROAR) StudyAnna L Johannsen, Morgan E Danowski, Kailyn E Sitter, et al.
NEJM Evidence|February 6, 2024
RNA Interference Therapy Targeting Apolipoprotein C-III in HypertriglyceridemiaDaniel Gaudet, Peter Clifton, David Sullivan, et al.
Pageof 32

Showing results (241-250 of 315) with videos related to

Sort By:
Pageof 32
Genome Biology|December 23, 2006
Three-dimensional morphology and gene expression in the Drosophila blastoderm at cellular resolution I: data acquisition pipelineCris L Luengo Hendriks, Soile V E Keränen, Charless C Fowlkes, et al.
The Lancet. Diabetes & Endocrinology|December 21, 2025
Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trialFrederick J Raal, Jean Bergeron, Daniel Gaudet, et al.
Circulation. Genomic and Precision Medicine|February 10, 2022
Coronary Artery Disease Risk of Familial Hypercholesterolemia Genetic Variants Independent of Clinically Observed Longitudinal Cholesterol ExposureShoa L Clarke, Catherine Tcheandjieu, Austin T Hilliard, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 30, 2015
A second transmissible cancer in Tasmanian devilsRuth J Pye, David Pemberton, Cesar Tovar, et al.
Nature Medicine|August 25, 2023
RNA interference targeting ANGPTL3 for triglyceride and cholesterol lowering: phase 1 basket trial cohortsGerald F Watts, Christian Schwabe, Russell Scott, et al.
Circulation|July 21, 2022
Creation of the American Heart Association Journals' Equity, Diversity, and Inclusion Editorial Board: The Next Step to Achieving the 2024 Impact GoalEldrin F Lewis, Christine Beaty, Johannes Boltze, et al.
The Journal of Pediatrics|September 25, 2020
Children with Heterozygous Familial Hypercholesterolemia in the United States: Data from the Cascade Screening for Awareness and Detection-FH RegistrySarah D de Ferranti, Peter Shrader, MacRae F Linton, et al.
Human Molecular Genetics|April 30, 2008
Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE studyThemistocles L Assimes, Joshua W Knowles, Analabha Basu, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 23, 2025
Primary care providers' perspectives on receiving opportunistic genomic results from a national study: The Million Veteran Program Return Of Actionable Results (MVP-ROAR) StudyAnna L Johannsen, Morgan E Danowski, Kailyn E Sitter, et al.
NEJM Evidence|February 6, 2024
RNA Interference Therapy Targeting Apolipoprotein C-III in HypertriglyceridemiaDaniel Gaudet, Peter Clifton, David Sullivan, et al.
Pageof 32